Fig. 7From: Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemiaPPI network of BBR and lipid markers targets against HLP (A). The “BBR-target-metabolite” network (B). The “screened key BBR-predicted target-lipid target” network. (Blue: BBR, Orange: predicted-targets, Purple: lipid metabolite targets, Green: metabolites) (C)Back to article page